Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates
CPRXCatalyst Pharmaceuticals(CPRX) Zacks Investment Research·2024-02-29 09:21

Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of 0.53pershare,beatingtheZacksConsensusEstimateof0.53 per share, beating the Zacks Consensus Estimate of 0.48 per share. This compares to earnings of 0.22pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof10.420.22 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 10.42%. A quarter ago, it was expected that this specialty drug company would post a loss of 0.24 per share when it actually produced a loss of $0.24, delivering no surprise. Over the last four quarters, ...